Showing results (151-160 of 220) with videos related to

Sort By:
Pageof 22
Scandinavian Journal of Public Health. Supplement|October 30, 2001
Different outcomes for different interventions with different focus!--A cross-country comparison of community interventions in rural Swedish and US populationsL Weinehall, C Lewis, A N Nafziger, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 11, 2009
Effect of intravenous flumazenil on oral midazolam pharmacokinetics and pharmacodynamics for use as a cytochrome P450 3A probeJ D Ma, N M Lawendy, T Fullerton, et al.
Federation Proceedings|December 1, 1986
Molecular forms of acetylcholinesterases in Alzheimer's diseaseS G Younkin, B Goodridge, J Katz, et al.
Experimental Hematology|October 13, 2005
A new model of pre-B acute lymphoblastic leukemia chemically induced in ratsNatacha Bernard, Lionel Devevey, Céline Jacquemont, et al.
Scandinavian Journal of Public Health. Supplement|October 30, 2001
The Norsjö-Cooperstown healthy heart project: a case study combining data from different studies without the use of meta-analysisP L Jenkins, L Weinehall, T A Erb, et al.
Academic Radiology|September 19, 2003
Using a human visual system model to optimize soft-copy mammography display: influence of MTF compensationElizabeth A Krupinski, Jeffrey Johnson, Hans Roehrig, et al.
The Journal of Infectious Diseases|January 1, 1993
Incidence of and significant risk factors for aminoglycoside-associated nephrotoxicity in patients dosed by using individualized pharmacokinetic monitoringJ S Bertino, L A Booker, P A Franck, et al.
Clinical Pharmacology and Therapeutics|October 3, 1998
Quantification of 3-month intraindividual variability and the influence of sex and menstrual cycle phase on CYP3A activity as measured by phenotyping with intravenous midazolamA D Kashuba, J S Bertino, M L Rocci, et al.
Scandinavian Journal of Public Health. Supplement|October 30, 2001
Design issues in the combination of international data from two rural community cardiovascular intervention programsA N Nafziger, L Weinehall, C Lewis, et al.
Clinical Pharmacology and Therapeutics|December 24, 2002
Flumazenil reduces midazolam-induced cognitive impairment without altering pharmacokineticsJanyce F Rogers, Ashley L Morrison, Anne N Nafziger, et al.
Pageof 22